Medically reviewed by Gagandeep Brar, MD Stage 1 and 2 prostate cancer stays in your prostate, and the five-year survival ...
SINGAPORE—For many men, a prostate cancer diagnosis can bring immediate fears about surgery, lengthy hospital stays and a difficult recovery. But advances in urology are changing that picture. From ...
Genitourinary cancers, prostate cancer chief among them, often present patients with more than one reasonable path forward. Dr. Yu-Wei Chen, a medical oncologist at UC San Diego Health, spoke with ...
As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...
Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery ...
After receiving a prostate cancer diagnosis and experiencing the many emotions that can come with it, deciding on a course of treatment can be overwhelming. It’s daunting to want to make the right ...
The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...
When a patient learns they have metastatic castration-sensitive prostate cancer (mCSPC), it often marks the beginning of a ...
A Dec. 29 Instagram post (direct link, archive link) shows a woman speaking over a screenshot of an X post that claims to share news about Israeli Prime Minister Benjamin Netanyahu. "BREAKING: Head of ...
A robotic water jet assisted by AI is helping men with enlarged prostates regain their quality of life, with one patient ...
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results